- Home
- IPDN vs SBFM Comparison
IPDN vs SBFM Comparison
Compare IPDN & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- SBFM
- Stock Information
- Founded
- IPDN 2003
- SBFM 2006
- Country
- IPDN United States
- SBFM United States
- Employees
- IPDN N/A
- SBFM N/A
- Industry
- IPDN EDP Services
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- SBFM Health Care
- Exchange
- IPDN Nasdaq
- SBFM Nasdaq
- Market Cap
- IPDN 11.1M
- SBFM 3.7M
- IPO Year
- IPDN 2013
- SBFM N/A
- Fundamental
- Price
- IPDN $0.89
- SBFM $3.14
- Analyst Decision
- IPDN
- SBFM
- Analyst Count
- IPDN 0
- SBFM 0
- Target Price
- IPDN N/A
- SBFM N/A
- AVG Volume (30 Days)
- IPDN 236.3K
- SBFM 90.8K
- Earning Date
- IPDN 11-12-2024
- SBFM 11-11-2024
- Dividend Yield
- IPDN N/A
- SBFM N/A
- EPS Growth
- IPDN N/A
- SBFM N/A
- EPS
- IPDN N/A
- SBFM N/A
- Revenue
- IPDN $7,319,905.00
- SBFM $30,481,982.00
- Revenue This Year
- IPDN N/A
- SBFM $86.70
- Revenue Next Year
- IPDN N/A
- SBFM $126.76
- P/E Ratio
- IPDN N/A
- SBFM N/A
- Revenue Growth
- IPDN N/A
- SBFM 109.82
- 52 Week Low
- IPDN $0.42
- SBFM $2.42
- 52 Week High
- IPDN $3.01
- SBFM $660.00
- Technical
- Relative Strength Index (RSI)
- IPDN 59.33
- SBFM 52.62
- Support Level
- IPDN $0.77
- SBFM $2.85
- Resistance Level
- IPDN $0.97
- SBFM $3.05
- Average True Range (ATR)
- IPDN 0.14
- SBFM 0.14
- MACD
- IPDN -0.00
- SBFM 0.03
- Stochastic Oscillator
- IPDN 35.95
- SBFM 85.29
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.